CD274 and neoplasm: While tumor PD-L1 positivity by immunohistochemistry has long been considered the gold standard for predicting responses to PD-1/PD-L1 inhibition, there is now mounting evidence that PD-1/PD-L1 expression on tumor infiltrating lymphocytes may also have predictive value, though this requires further investigation [30,31].